Cisatracurium Besylate Injection and Eskalith

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Using cisatracurium together with lithium may increase the effects of cisatracurium. You should be closely monitored for prolong breathing cessation. You may need a dose adjustment or special test if you use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

MONITOR: Limited data suggest that lithium may potentiate the pharmacologic effects of neuromuscular blocking agents. The exact mechanism of interaction is unknown. There have been isolated reports of prolonged apnea and delayed recovery from anesthesia in patients treated with lithium who were administered a neuromuscular blocking agent (succinylcholine or pancuronium) during surgery. Additional data have come from animal studies, thus clinical significance of the interaction has not been determined.

MANAGEMENT: Caution is advised if neuromuscular blocking agents are used in patients who have been treated with lithium. Patients should be monitored closely for development of respiratory depression, and life support should be readily available if needed.

Cisatracurium Besylate Injection

Generic Name: cisatracurium

Brand name: Nimbex

Synonyms: Cisatracurium

What is Cisatracurium Besylate Injection?

Eskalith

Generic Name: lithium

Brand name: Eskalith, Lithobid, Lithonate, Lithotabs, Eskalith-CR

Synonyms: n.a.

What is Eskalith?